<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Wang Y</submitter><funding>the Key Development Project of Science and Technology Bureau in Xuzhou (Social development)</funding><funding>the Project supported by Xuzhou Medical University</funding><funding>the Key Laboratory of Jiangsu Province Open project</funding><funding>the Project supported by the Affiliated Hospital of Xuzhou Medical University</funding><pagination>20</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11762886</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>44(1)</volume><pubmed_abstract>&lt;h4>Aims&lt;/h4>This study aims to assess the serum levels of pepsinogen (PG)I, PG II, and gastrin (G17) in patients with gastric intestinal metaplasia (GIM) and evaluate their correlation with demographic characteristics.&lt;h4>Methods&lt;/h4>A total of 247 normal controls (NC) and 240 patients diagnosed with GIM were enrolled in this study. All participants underwent a gastroscopy procedure followed by pathological examination for diagnosis confirmation. The expression level of PGI, PG II, and G 17 was detected by fluorescence immunochromatography and Hp infection was detected by 13-carbon breath test. The demographic characteristics of the subjects were obtained through questionnaires.&lt;h4>Results&lt;/h4>Compared to the NC group, the GIM group showed a reduction in PG II expression level [10.71(6.40</pubmed_abstract><journal>Journal of health, population, and nutrition</journal><pubmed_title>Hp eradication decreased the expression level of PG II in patients of Hp negative with gastric intestinal metaplasia: a retrospective cross-sectional study.</pubmed_title><pmcid>PMC11762886</pmcid><funding_grant_id>SJCX24-1543</funding_grant_id><funding_grant_id>2023ZL19</funding_grant_id><funding_grant_id>KC22233</funding_grant_id><funding_grant_id>XZSYSKF2021029</funding_grant_id><pubmed_authors>Cao X</pubmed_authors><pubmed_authors>Li S</pubmed_authors><pubmed_authors>Fei S</pubmed_authors><pubmed_authors>Wang Y</pubmed_authors><pubmed_authors>Chen S</pubmed_authors><pubmed_authors>Pang X</pubmed_authors><pubmed_authors>Shan B</pubmed_authors></additional><is_claimable>false</is_claimable><name>Hp eradication decreased the expression level of PG II in patients of Hp negative with gastric intestinal metaplasia: a retrospective cross-sectional study.</name><description>&lt;h4>Aims&lt;/h4>This study aims to assess the serum levels of pepsinogen (PG)I, PG II, and gastrin (G17) in patients with gastric intestinal metaplasia (GIM) and evaluate their correlation with demographic characteristics.&lt;h4>Methods&lt;/h4>A total of 247 normal controls (NC) and 240 patients diagnosed with GIM were enrolled in this study. All participants underwent a gastroscopy procedure followed by pathological examination for diagnosis confirmation. The expression level of PGI, PG II, and G 17 was detected by fluorescence immunochromatography and Hp infection was detected by 13-carbon breath test. The demographic characteristics of the subjects were obtained through questionnaires.&lt;h4>Results&lt;/h4>Compared to the NC group, the GIM group showed a reduction in PG II expression level [10.71(6.40</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Jan</publication><modification>2025-04-21T23:50:22.54Z</modification><creation>2025-04-05T19:21:58.886Z</creation></dates><accession>S-EPMC11762886</accession><cross_references><pubmed>39856761</pubmed><doi>10.1186/s41043-025-00756-y</doi></cross_references></HashMap>